Anandamide is also a lipid mediator that functions as an endogenous ligand (a protein that binds to a recptor) by attaching itself to the body’s CB1 receptors, the primary molecular target that’s responsible for the pharmacological effects of THC. Anandamide was discovered in the early ‘90s by Dr. Raphael Mechoulam, who was known for his groundbreaking research and discovery of delta-9-THC while trying to figure out why our bodies contained cannabinoid receptors that are capable of binding with external cannabinoids such as CBD and THC.
Slapwoods is announcing its first-ever official collaboration with DJ Screw, the late Houston legend whose…
It could be so easy to believe that cannabis culture is something that has been…
Modern cultivation techniques and spiritual practices collide with Pink Boost Goddess on our next Legendary…
Animal rescuers and advocacy groups say dogs living on Skid Row are suffering from neglect,…
This article originally appeared in High Times’ 50th Anniversary print issue. It is an excerpt…
How Montana built a legal cannabis market from a thin medical marijuana law, federal raids,…